Phage approved in food, why not as a therapeutic? (Q38285489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

review article

1 reference

title

Phage approved in food, why not as a therapeutic? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Wessam A Sarhan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

91-101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25488141%20AND%20SRC:MED&resulttype=core&format=json

AN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES.

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophage applications: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage therapy in the food industry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophage adhering to mucus provide a non-host-derived immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Old dogma, new tricks--21st Century phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

The WHO policy package to combat antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Race against time to develop new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Treatment of experimental infections of mice with bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Use of bacteriophages in combination with competitive exclusion to reduce Salmonella from infected chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Antibiotic-induced biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Application of a group II Campylobacter bacteriophage to reduce strains of Campylobacter jejuni and Campylobacter coli colonizing broiler chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Significance of the bacteriophage treatment schedule in reducing Salmonella colonization of poultry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduceEscherichia coliO157

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage inactivation of foodborne Shigella on ready-to-eat spiced chicken

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Biocontrol of Salmonella Typhimurium in RTE foods with the virulent bacteriophage FO1-E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Enterobacter sakazakii bacteriophages can prevent bacterial growth in reconstituted infant formula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Reduction of Escherichia coli O157:H7 viability on leafy green vegetables by treatment with a bacteriophage mixture and trans-cinnamaldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Biocontrol of Escherichia coli O157: H7 on fresh-cut leafy greens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

21 January 2018

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage treatment of human infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage-based biocontrol strategies to reduce foodborne pathogens in foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Foodborne illness acquired in the United States--major pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

The role of regulated clinical trials in the development of bacteriophage therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

The prospect for bacteriophage therapy in Western medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

The next generation of bacteriophage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Long-circulating bacteriophage as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

The interactions of peptides with the innate immune system studied with use of T7 phage peptide display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Uptake and processing of modified bacteriophage M13 in mice: implications for phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Pharmacokinetic principles of bacteriophage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

THE MULTIPLICATION OF BACTERIOPHAGE IN VIVO AND ITS PROTECTIVE EFFECT AGAINST AN EXPERIMENTAL INFECTION WITH SHIGELLA DYSENTERIAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Genetically modified filamentous phage as bactericidal agents: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Extending filamentous phage host range by the grafting of a heterologous receptor binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Escherichia coli K1's capsule is a barrier to bacteriophage T7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Modified phages: novel antimicrobial agents to combat infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophage resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage choice, isolation, and preparation for phage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Biotechnological challenges of phage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Purification of the Staphylococcus aureus bacteriophages VDX-10 on methacrylate monoliths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Phage Therapy in Clinical Practice: Treatment of Human Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

European regulatory conundrum of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Gold and silver nanoparticles for clinical diagnostics - From genomics to proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Electrospun water-soluble polymer nanofibers for the dehydration and storage of sensitive reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383

Immunocompatibility of Bacteriophages as Nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.990383